DE60119919D1 - Freie aminosäure enthaltende zusammensetzung - Google Patents

Freie aminosäure enthaltende zusammensetzung

Info

Publication number
DE60119919D1
DE60119919D1 DE60119919T DE60119919T DE60119919D1 DE 60119919 D1 DE60119919 D1 DE 60119919D1 DE 60119919 T DE60119919 T DE 60119919T DE 60119919 T DE60119919 T DE 60119919T DE 60119919 D1 DE60119919 D1 DE 60119919D1
Authority
DE
Germany
Prior art keywords
aminoic
free
composition
administering
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60119919T
Other languages
English (en)
Other versions
DE60119919T2 (de
Inventor
Constance Whippie
Olivier Ballevre
Julio Boza
Paul-Andre Finot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of DE60119919D1 publication Critical patent/DE60119919D1/de
Application granted granted Critical
Publication of DE60119919T2 publication Critical patent/DE60119919T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE60119919T 2000-04-12 2001-03-21 Freie aminosäure enthaltende zusammensetzung Expired - Lifetime DE60119919T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0009056.3A GB0009056D0 (en) 2000-04-12 2000-04-12 Composition comprising free amino acids
GB0009056 2000-04-12
PCT/EP2001/003188 WO2001078532A1 (en) 2000-04-12 2001-03-21 Composition comprising free amino acids

Publications (2)

Publication Number Publication Date
DE60119919D1 true DE60119919D1 (de) 2006-06-29
DE60119919T2 DE60119919T2 (de) 2007-04-26

Family

ID=9889802

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60119919T Expired - Lifetime DE60119919T2 (de) 2000-04-12 2001-03-21 Freie aminosäure enthaltende zusammensetzung

Country Status (17)

Country Link
US (3) US20040096478A1 (de)
EP (1) EP1274322B1 (de)
JP (1) JP5600232B2 (de)
KR (1) KR20020089448A (de)
CN (1) CN1243542C (de)
AT (1) ATE326867T1 (de)
CA (1) CA2404005C (de)
DE (1) DE60119919T2 (de)
ES (1) ES2263602T3 (de)
GB (1) GB0009056D0 (de)
HK (1) HK1054489A1 (de)
HU (1) HUP0300299A3 (de)
MX (1) MXPA02010058A (de)
NO (1) NO324525B1 (de)
PL (1) PL358876A1 (de)
RU (1) RU2002130204A (de)
WO (1) WO2001078532A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
DE10221403A1 (de) * 2002-05-14 2003-12-04 Kyberg Pharma Vertriebs Gmbh & Diätetische und pharmazeutische Zusammensetzungen, ihre Herstellung und ihre Verwendung
US6592908B1 (en) * 2002-09-23 2003-07-15 Albert Crum Nutritional or therapeutic compositions
EP2382874A1 (de) 2003-06-23 2011-11-02 Nestec S.A. Aminosäureergänzung für ein gesundes mikrobiotisches Ökosystem
US20050053673A1 (en) * 2003-09-05 2005-03-10 Shrirang Netke Composition and method for facilitating bone healing
DK1543735T3 (en) * 2003-12-20 2015-11-02 Nestec Sa FOOD COMPOSITION FOR HEALTH CARE
WO2005110124A1 (en) * 2004-04-15 2005-11-24 Abbott Laboratories Composition and methods for nutritional management of patients with hepatic disease
EP1767201B8 (de) * 2004-06-28 2012-02-29 Ajinomoto Co., Inc. Nährstoffzusammensetzung und zusammensetzung zur prävention/mitigation von verdauungstraktdepression
EP1806134B1 (de) 2004-09-17 2012-07-11 Ajinomoto Co., Inc. Mittel und nahrungsmittel zur prävention/verbesserung von funktionalen verdauungsstörungen
EP1890688A2 (de) * 2005-06-14 2008-02-27 Nestec S.A. Ernährungsmethode
EP1920770A4 (de) * 2005-07-01 2010-09-29 Ajinomoto Kk Therapeutisches mittel gegen entzündliche darmerkrankung und tnf-alpha-produktionshemmer
JP4916143B2 (ja) * 2005-08-04 2012-04-11 サッポロビール株式会社 ビール酵母で発酵させたアルコール飲料からコラーゲン産生促進作用を有する組成物を製造する方法及びその組成物
EP2668957A1 (de) * 2005-08-29 2013-12-04 Ajinomoto Co., Inc. Nährstoffzusammensetzung
US8722120B2 (en) 2006-08-02 2014-05-13 Mead Johnson Nutrition Company Amino acid-based nutritional formulations
JPWO2009113594A1 (ja) * 2008-03-11 2011-07-21 味の素株式会社 機能性消化管障害予防・改善剤および食品
WO2011021926A1 (en) * 2009-08-21 2011-02-24 N.V. Nutricia Regulating the amino acid pool used for the acute-phase protein synthesis
CN102883626A (zh) * 2009-11-25 2013-01-16 雀巢产品技术援助有限公司 包括高蛋白质成分和外源性核苷酸的营养组合物
JP2011121889A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011121888A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011121887A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011144116A (ja) * 2010-01-12 2011-07-28 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用添加剤
AP2013006826A0 (en) 2010-09-24 2013-04-30 Univ Florida Materials and methods for improving gastrointestinal function
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
CN110522744B (zh) 2013-03-11 2023-04-07 佛罗里达大学研究基金会有限公司 用于改善肺功能和用于预防和/或治疗辐射诱发的肺并发症的材料和方法
JP6450689B2 (ja) * 2014-01-17 2019-01-09 株式会社明治 食後早期飽満感または胃食道逆流症の予防または改善剤
WO2015167002A1 (ja) * 2014-04-30 2015-11-05 味の素株式会社 消化管障害を改善する組成物
CA2968831A1 (en) 2014-11-24 2016-06-02 Entrinsic Health Solutions, Llc Amino acid compositions for the treatment of symptoms of disease
US11234949B2 (en) * 2015-05-14 2022-02-01 Professional Dietetics S.P.A. Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
JP6841223B2 (ja) 2015-06-10 2021-03-10 味の素株式会社 運動誘発性の消化管障害の改善剤
EP3310354A4 (de) * 2015-06-17 2018-12-12 Dispersol Technologies, LLC Verbesserte formulierungen von deferasirox und verfahren zur herstellung davon
CN105747214A (zh) * 2016-02-26 2016-07-13 四川安益生物科技有限公司 一种支链氨基酸组合物
JP7267546B2 (ja) 2016-10-04 2023-05-02 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド アミノ酸組成物及びその使用
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
DE102017201713A1 (de) 2017-02-02 2018-08-02 artgerecht GmbH Zusammensetzung mit Aminosäuren
EP3357352B1 (de) 2017-02-02 2021-03-24 artgerecht GmbH Zusammensetzung mit aminosäuren
WO2018200477A1 (en) * 2017-04-25 2018-11-01 Almeda Labs Llc Amino acid formulations for pancreatic viability
WO2019036471A1 (en) 2017-08-14 2019-02-21 Axcella Health Inc. AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE
JP2019058140A (ja) * 2017-09-27 2019-04-18 味の素株式会社 栄養組成物
TW201932483A (zh) * 2018-01-16 2019-08-16 林文欽 用於形成膠原蛋白的氨基酸組成物
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 筋肉中の脂肪浸潤の治療のための組成物及び方法
JP2022531891A (ja) * 2019-05-08 2022-07-12 マイコテクノロジー，インコーポレーテッド 菌糸化された増量組成物の製造方法
CN111067885A (zh) * 2020-02-20 2020-04-28 杨益文 一种消除幽门螺旋螺杆菌及治疗胃及十二指肠溃疡的药物
US20230089723A1 (en) * 2020-03-06 2023-03-23 Axcella Health Inc. Amino acid compositions and methods for muscle and myotube modulation
EP4418880A1 (de) * 2021-10-21 2024-08-28 Société des Produits Nestlé S.A. Zusammensetzung

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT945910B (it) * 1971-04-08 1973-05-10 Erra C Spa Prodotto dietetico impiegabile quale intergratore dell alimenta zione umana con particolare riferi mento all infanzia agli stati di convalescenza di gravidanza d allat tamento e dell eta senile e procedi mento per la sua fabbricazione
US4053589A (en) * 1975-11-24 1977-10-11 Control Drug Inc. Method of treating nutritional deficiency during cardiac cachexia, diabetes, hypoglycemia, gastroenterology, lipid, cell glycogen and keratin-related skin conditions and alcoholism
US4042687A (en) * 1975-11-24 1977-08-16 Control Drug, Inc. Method of treating obesity by the oral administration of a predigested protein composition
US4414238A (en) * 1981-12-24 1983-11-08 Cutter Laboratories, Inc. Liquid elemental diet
FR2556594B1 (fr) * 1983-12-20 1988-09-09 Synthelabo Solutions d'acides amines
GB2223925A (en) * 1988-09-09 1990-04-25 Stiff John Edward Dietary supplements
US5292773A (en) * 1990-02-14 1994-03-08 Hirsch Gerald P Treating aids and HIV infection with methionine
US5106836A (en) * 1991-02-22 1992-04-21 Clintec Nutrition Co. Enteral diet
AU679020B2 (en) * 1992-12-23 1997-06-19 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
RU2091067C1 (ru) * 1994-05-30 1997-09-27 Мыслицкая Людмила Николаевна Способ лечения желудочно-кишечных заболеваний
RU2080871C1 (ru) * 1994-05-30 1997-06-10 Макаров Николай Васильевич Средство, обладающее регенеративной активностью
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
ES2132021B1 (es) * 1997-05-28 2000-02-16 Riera Simon Schwartz Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas.
EP1123013A1 (de) 1997-06-02 2001-08-16 Société des Produits Nestlé S.A. Produkt und verfahren zur versehung von glutamine
DE69834929T2 (de) 1997-09-16 2007-02-01 Société des Produits Nestlé S.A. Verwendung eines organspezifischen ernährungsmittels

Also Published As

Publication number Publication date
NO324525B1 (no) 2007-11-12
JP5600232B2 (ja) 2014-10-01
EP1274322A1 (de) 2003-01-15
PL358876A1 (en) 2004-08-23
CA2404005C (en) 2009-12-08
NO20024743D0 (no) 2002-10-02
US20120035234A1 (en) 2012-02-09
DE60119919T2 (de) 2007-04-26
CN1422125A (zh) 2003-06-04
US20040096478A1 (en) 2004-05-20
EP1274322B1 (de) 2006-05-24
CN1243542C (zh) 2006-03-01
KR20020089448A (ko) 2002-11-29
CA2404005A1 (en) 2001-10-25
RU2002130204A (ru) 2004-03-27
NO20024743L (no) 2002-12-03
ATE326867T1 (de) 2006-06-15
GB0009056D0 (en) 2000-05-31
HUP0300299A3 (en) 2005-01-28
US8067471B2 (en) 2011-11-29
WO2001078532A1 (en) 2001-10-25
US8383680B2 (en) 2013-02-26
MXPA02010058A (es) 2003-03-10
US20060247312A1 (en) 2006-11-02
HUP0300299A2 (hu) 2003-07-28
JP2003530411A (ja) 2003-10-14
ES2263602T3 (es) 2006-12-16
HK1054489A1 (zh) 2003-12-05

Similar Documents

Publication Publication Date Title
DE60119919D1 (de) Freie aminosäure enthaltende zusammensetzung
CA2219502A1 (en) Methods and formulations for modulating the human sexual response
CA2255652A1 (en) Isobutylgaba and its derivatives for the treatment of pain
HUP9701540A1 (hu) A gasztrointesztinális keringést elősegítő gyógyászati készítmény
DE69625691D1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
DK1137762T3 (da) Behandling af Pompes sygdom
DE59811158D1 (de) Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
HUP0001014A2 (hu) Gasztrointesztinális lipáz inhibitorok felhasználása
FI940659A0 (fi) Heterosyklisesti substituoituja fenyylisykloheksaanikarboksyylihappojohdannaisia
WO2002064148A3 (en) Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders
DE69943107D1 (de) Behandlung von autoimmunerkrankungen
PT998287E (pt) Utilizacao de levobupivacaina
DE69614375D1 (de) Dermatologische zubereitung zur behandlung von aktinischen keratosen
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
HUP0202525A2 (hu) Mofetil mikofenolát és PEG-IFN-alfa együttes alkalmazása, valamint az azokat tartalmazó gyógyszerkészítmények és kit
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
ES2145517T3 (es) Nuevos derivados monofuncionalizados de edta, dtpa y ttha y su utilizacion en el diagnostico y en la terapia medicinales.
FR2618439B1 (fr) Sequences d'amino-acides reproduisant au moins en partie la sequence des lectines animales et humaines, leurs procedes d'obtention, leurs applications diagnostiques et therapeutiques
MD1469G2 (ro) Metodă de tratament al şocului combustional
HUP0200148A2 (hu) N-(3',4'-dimetoxi-cinnamoil)antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére
MY117556A (en) Methods and formulations for modulating the human sexual response
UA38388A (uk) Спосіб лікування епідемічного паротиту
HUP0200129A2 (hu) N-(3'4'-dimetoxi-cinnamoil)-antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére
GEP20053457B (en) Low Hygroscopic Aripiprazole Drug Substance and Processes for Preparation Thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition